NCT02426021View on ClinicalTrials.gov

Phase 1 Single Subcutaneous Dose Study of MLN1202

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Healthy Japanese and Caucasian Male Adults
Interventions
DRUG

MLN1202

Subcutaneous administration of MLN1202

DRUG

MLN1202 Placebo

Subcutaneous administration of MLN1202 placebo

Trial Locations (1)

Unknown

Sumida-ku

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY